Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 8
2004 10
2005 9
2006 9
2007 12
2008 12
2009 11
2010 11
2011 10
2012 11
2013 14
2014 11
2015 14
2016 7
2017 5
2018 8
2019 8
2020 4
2021 1
2022 3
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Minocycline on Depressive Symptoms in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
Hellmann-Regen J, Clemens V, Grözinger M, Kornhuber J, Reif A, Prvulovic D, Goya-Maldonado R, Wiltfang J, Gruber O, Schüle C, Padberg F, Ising M, Uhr M, Friede T, Huber C, Manook A, Baghai TC, Rupprecht R, Heuser I. Hellmann-Regen J, et al. Among authors: uhr m. JAMA Netw Open. 2022 Sep 1;5(9):e2230367. doi: 10.1001/jamanetworkopen.2022.30367. JAMA Netw Open. 2022. PMID: 36103181 Free PMC article. Clinical Trial.
ABCB1 genotyping in the treatment of depression.
Brückl TM, Uhr M. Brückl TM, et al. Among authors: uhr m. Pharmacogenomics. 2016 Dec;17(18):2039-2069. doi: 10.2217/pgs.16.18. Epub 2016 Dec 5. Pharmacogenomics. 2016. PMID: 27918249 Review.
Therapeutic Reference Range for Olanzapine in Schizophrenia: Systematic Review on Blood Concentrations, Clinical Effects, and Dopamine Receptor Occupancy.
Wesner K, Hiemke C, Bergemann N, Egberts KM, Fekete S, Gerlach M, Havemann-Reinecke U, Lense XM, Riemer TG, Schoretsanitis G, Uhr M, Zernig G, Gründer G, Hart XM. Wesner K, et al. Among authors: uhr m. J Clin Psychiatry. 2023 Jul 19;84(5):22r14626. doi: 10.4088/JCP.22r14626. J Clin Psychiatry. 2023. PMID: 37471567
TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians<sup/>
Schoretsanitis G, Paulzen M, Unterecker S, Schwarz M, Conca A, Zernig G, Gründer G, Haen E, Baumann P, Bergemann N, Clement HW, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Havemann-Reinecke U, Hefner G, Helmer R, Janssen G, Jaquenoud-Sirot E, Laux G, Messer T, Mössner R, Müller MJ, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Silva Gracia M, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Waschgler R, Zurek G, Hiemke C. Schoretsanitis G, et al. Among authors: uhr m. World J Biol Psychiatry. 2018 Apr;19(3):162-174. doi: 10.1080/15622975.2018.1439595. Epub 2018 Mar 1. World J Biol Psychiatry. 2018. PMID: 29493375 Review.
[Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP].
Unterecker S, Hefner G, Baumann P, Gründer G, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, Eckermann G, Egberts K, Gerlach M, Greiner C, Haen E, Havemann-Reinecke U, Helmer R, Janssen G, Jaquenoud E, Laux G, Messer T, Mössner R, Müller MJ, Paulzen M, Pfuhlmann B, Riederer P, Saria A, Schoppek B, Schoretsanitis G, Schwarz M, Gracia MS, Stegmann B, Steimer W, Stingl JC, Uhr M, Ulrich S, Waschgler R, Zernig G, Zurek G, Hiemke C. Unterecker S, et al. Among authors: uhr m. Nervenarzt. 2019 May;90(5):463-471. doi: 10.1007/s00115-018-0643-9. Nervenarzt. 2019. PMID: 30446893 Review. German.
Weight-gain independent effect of mirtazapine on fasting plasma lipids in healthy men.
Lechner K, Heel S, Uhr M, Dose T, Holsboer F, Lucae S, Schaaf L, Fulda S, Kloiber S, Hennings JM. Lechner K, et al. Among authors: uhr m. Naunyn Schmiedebergs Arch Pharmacol. 2023 Sep;396(9):1999-2008. doi: 10.1007/s00210-023-02448-y. Epub 2023 Mar 9. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 36890393 Free PMC article.
Stress-responsive FKBP51 regulates AKT2-AS160 signaling and metabolic function.
Balsevich G, Häusl AS, Meyer CW, Karamihalev S, Feng X, Pöhlmann ML, Dournes C, Uribe-Marino A, Santarelli S, Labermaier C, Hafner K, Mao T, Breitsamer M, Theodoropoulou M, Namendorf C, Uhr M, Paez-Pereda M, Winter G, Hausch F, Chen A, Tschöp MH, Rein T, Gassen NC, Schmidt MV. Balsevich G, et al. Among authors: uhr m. Nat Commun. 2017 Nov 23;8(1):1725. doi: 10.1038/s41467-017-01783-y. Nat Commun. 2017. PMID: 29170369 Free PMC article.
160 results